(Press-News.org) New Rochelle, NY, August 7, 2012—The global market value of Alzheimer's disease therapeutics could soar to the $8 billion range once therapeutics are approved that actually change the course of the disease, reports Genetic Engineering & Biotechnology News (GEN). The current therapeutic market is valued at $3 to $4 billion, shared among drugs that temporarily delay disease progression or address the symptoms but do not alter the underlying disease, according to a recent issue of GEN.
"Despite all the research on amyloid plaques and neurofibrillary tangles there is still a debate on whether these biological phenomena are causative or symptomatic of Alzheimer's," said John Sterling, Editor-in-Chief of GEN. "Once scientists can clearly and unequivocally define key factors related to the actual biology of the disease itself, therapeutic advances could take place much more quickly."
More than 150 companies are working in the Alzheimer's space, including approximately 15 multinationals and 30 generics companies. A number of these firms are taking innovative approaches to tackling this extremely debilitating disease. For example, the USPTO in March granted a patent for Antisenilin, developed by Intellect Neurosciences. This therapy, which targets either end of ß-amyloid, is in Phase III trials.
Baxter has a Phase III program under way for Gammagard, a naturally occurring plasma-derived immunoglobulin for moderate-stage AD patients. The trial runs until February 2013. Phase II results suggest Gammagard may positively affect brain atrophy and cognition. The compound already is approved for immunodeficiency diseases.
Other companies covered in the GEN article include AstraZeneca, Roche, TransTech Pharma, Astex Pharmaceuticals, Memory Pharmaceuticals, Sanofi-Aventis, Eli Lilly, GE Healthcare Life Sciences, and Charles River Laboratories.
INFORMATION:
For a copy of the August issue of GEN, please call (914) 740-2146, or email: pbartell@genengnews.com
Genetic Engineering & Biotechnology News, which is published 21 times a year by Mary Ann Liebert, Inc., is the most widely read biotechnology news magazine worldwide. It includes articles on Drug Discovery, Bioprocessing, OMICS, Biobusiness, and Translational Medicine.
GEN reports on recent progress in Alzheimer's research
2012-08-08
ELSE PRESS RELEASES FROM THIS DATE:
Notre Dame researcher is shedding light on how jaws evolve
2012-08-08
If you're looking for information on the evolution and function of jaws, University of Notre Dame researcher Matt Ravosa is your man.
His integrative research program investigates major adaptive and morphological transformations in the mammalian musculoskeletal system during development and across higher-level groups. In mammals, the greater diversification and increasingly central role of the chewing complex in food procurement and processing has drawn considerable attention to the biomechanics and evolution of this system. Being among the most highly mineralized, and ...
Can nature parks save biodiversity?
2012-08-08
The 14 years of wildlife studies in and around Madagascar's Ranomafana National Park by Sarah Karpanty, associate professor of wildlife conservation at Virginia Tech's College of Natural Resources and Environment, and her students are summarily part of a paper on biodiversity published July 25 by Nature's Advanced Online Publication and coming out soon in print.
As human activities put increasing pressures on natural systems and wildlife to survive, 200 scientists around the world carved up pieces of the puzzle to present a clearer picture of reality and find ways to mitigate ...
Planting the seeds of defense
2012-08-08
LA JOLLA, CA----It was long thought that methylation, a crucial part of normal organism development, was a static modification of DNA that could not be altered by environmental conditions. New findings by researchers at the Salk Institute for Biological Studies, however, suggest that the DNA of organisms exposed to stress undergo changes in DNA methylation patterns that alter how genes are regulated.
The scientists found that exposure to a pathogenic bacteria caused widespread changes in a plant's epigenetic code, an extra layer of biochemical instructions in DNA that ...
Increasing federal match funds for states boosts enrollment of kids in health-care programs
2012-08-08
Ann Arbor, Mich. — Significantly more children get health insurance coverage after increases in federal matching funds to states for Medicaid and the Children's Health Insurance Program (CHIP), according to new research from the University of Michigan.
The research, published Monday in the journal Health Affairs, showed that a 10-percentage-point increase in the federal match for Medicaid and CHIP, similar to the increase that occurred with the American Reinvestment and Recovery Act, is associated with an increase of 1.9 percent in the number of children enrolled in ...
Infrared NASA imagery shows a weaker Tropical Storm 13W
2012-08-08
Infrared satellite imagery from shows how cold cloud top temperatures are in a tropical cyclone, and recent imagery from NASA's Aqua satellite shows the cloud-top temperatures have been warming in Tropical Storm 13W. Warming cloud top temperatures indicate less strength, and Tropical Storm 13W is weakening.
NASA's Aqua satellite passed over Tropical Storm 13W on August 7 at 0253 UTC. The Atmospheric Infrared Sounder (AIRS) instrument that flies onboard Aqua captured an infrared image of the storm's cloud temperatures that showed very limited strong thunderstorms make ...
NASA sees Tropical Storm Haikui closing in on China
2012-08-08
Tropical Storm Haikui is headed for landfall in southeastern China, and NASA's Aqua satellite caught a stunning image of its size and its ragged, but wide eye when it was a typhoon earlier today, August 7. As a result of interaction with land, Haikui has weakened to a tropical storm.
When NASA's Aqua satellite passed over Typhoon Haikui on August 6, 2012 at 12:35 a.m. EDT the Moderate Resolution Imaging Spectroradiometer (MODIS) instrument onboard captured an image of the storm as it was approaching China. The MODIS image clearly showed Haikui's ragged and elongated eye ...
NASA satellites revealed Tropical Storm Ernesto's strongest side
2012-08-08
Satellite data helps forecasters see where the strongest part of a tropical cyclone is located, and NASA's Aqua satellite noticed Ernesto's strongest storms were on the eastern side yesterday. Today, strong storms surround Ernesto's center.
A visible image of Tropical Storm Ernesto approaching Central America was captured by the Moderate Resolution Imaging Spectroradiometer (MODIS) instrument that flies onboard NASA's Aqua satellite. In an image captured on August 6, 2012 at 1840 UTC (2:40 p.m. EDT), the strongest thunderstorms appeared to be on the northern and eastern ...
COI declarations and off-label drug use
2012-08-08
Conflict-of-interest statements made by physicians and scientists in their medical journal articles after they had been allegedly paid by pharmaceutical manufacturers as part of off-label marketing programs are often inadequate, highlighting the deficiencies in relying on author candidness and the weaknesses in some journal practices in ensuring proper disclosure, according to a study by international researchers published in this week's PLOS Medicine. Off-label marketing is the promotion by a manufacturer of a drug for use in a condition or age group, or in a dose or form ...
NJIT scientist creates instrument for NASA Aug. 23 launch
2012-08-08
NJIT Distinguished Research Professor and former Bell Labs scientist Louis J. Lanzerotti, will see his 50-year quest to better understand space weather and Earth's Van Allen Radiation Belts rocket, once again, into space on Aug. 23, 2012. This is when NASA's twin Radiation Belt Storm Probes (RBSP) begin their mission to study the extremes of space weather. Lanzerotti, today one of the most respected and valued scientists behind space exploration, was the principal investigator to build one of five instruments aboard each of the two spacecraft that comprise the RBSP mission. ...
Integration of active tuberculosis case finding in a mobile HIV-testing clinic is feasible
2012-08-08
A research article by Katharina Kranzer from the London School of Hygiene & Tropical Medicine and colleagues describe the feasibility and costs of an active tuberculosis case finding project in Cape Town, South Africa.
The study describes the integration of tuberculosis testing into a mobile HIV testing service for HIV-negative individuals with symptoms suggestive of tuberculosis and all HIV-positive individuals.
The mobile testing clinic, named the Tutu Tester after Archbishop Emeritus Desmond Tutu, visits underserviced areas in greater Cape Town and provides testing ...